N-(2-bromobenzyl)-8-imino-4-methyl-2-oxo-2H,8H-pyrano[2,3-f]chromene-9 carboxamide

ID: ALA3746565

Chembl Id: CHEMBL3746565

PubChem CID: 127037909

Max Phase: Preclinical

Molecular Formula: C21H15BrN2O4

Molecular Weight: 439.26

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(=O)oc2c1ccc1oc(=N)c(C(=O)NCc3ccccc3Br)cc12

Standard InChI:  InChI=1S/C21H15BrN2O4/c1-11-8-18(25)28-19-13(11)6-7-17-14(19)9-15(20(23)27-17)21(26)24-10-12-4-2-3-5-16(12)22/h2-9,23H,10H2,1H3,(H,24,26)

Standard InChI Key:  RDRHSWAZLFORIL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3746565

    ---

Associated Targets(Human)

SK-N-SH (1499 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ache Acetylcholinesterase (12221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 439.26Molecular Weight (Monoisotopic): 438.0215AlogP: 4.02#Rotatable Bonds: 3
Polar Surface Area: 96.30Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.10CX LogP: 3.40CX LogD: 3.40
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.37Np Likeness Score: -0.69

References

1. Shaik JB, Palaka BK, Penumala M, Kotapati KV, Devineni SR, Eadlapalli S, Darla MM, Ampasala DR, Vadde R, Amooru GD..  (2016)  Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.,  107  [PMID:26588065] [10.1016/j.ejmech.2015.10.046]

Source